| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/26/2011 | CN101954078A Vaccine adjuvant for swine enzootic pneumonia vaccine and preparation method and application thereof |
| 01/26/2011 | CN101954077A Expression plasmid adjuvant for enhancing chemotherapeutic effect of tumor chemotherapeutics and preparation method thereof |
| 01/26/2011 | CN101954076A Immunotherapy and prevention of autoimmune hepatitis |
| 01/26/2011 | CN101954075A Method for preparing oral avian influenza vaccine from transgenic dunaliella |
| 01/26/2011 | CN101954074A Recombinant attenuated salmonella typhimurium vector vaccine expressing PCV-2 immunogenic gene and preparation method thereof |
| 01/26/2011 | CN101954073A Novel anti-tumor cell vaccine and preparation method thereof |
| 01/26/2011 | CN101481691B Trichinella spiralis 70KDa heat shock protein and use thereof |
| 01/26/2011 | CN101475640B Conjugate, and preparation and use thereof |
| 01/26/2011 | CN101461940B Photobacterium damsela vaccine as well as preparation method and use thereof |
| 01/26/2011 | CN101445789B Application of dominant negative mutant F427N as anthrax toxin inhibitor and vaccine |
| 01/26/2011 | CN101361971B Preparation technique of Vibrio vulnificus whole-cell immunity stimulated compound vaccine and use thereof in aquatic animal |
| 01/26/2011 | CN101265457B Vaccine for differentiating porcine actinobacillus pleuropneumonia serum 7-type double-gene deletion mutant of vaccine immunity and virus infection animal and application thereof |
| 01/26/2011 | CN101199483B Stable anti-HER2 humanized antibody preparation |
| 01/26/2011 | CN101095950B Hydrophobia vaccine freezing drying preparations for stable human beings and the preparations thereof |
| 01/25/2011 | US7875594 Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents |
| 01/25/2011 | US7875585 Hematopoietic cell E-selectin / L-selectin ligand glycosylated CD44 polypeptide |
| 01/25/2011 | US7875450 Virus-like particles for the induction of autoantibodies |
| 01/25/2011 | US7875446 Purification processes for isolating purified vesicular stomatitis virus from cell culture |
| 01/25/2011 | US7875439 Nucleotide sequences coding bacterial surface protein for use in development of vaccines and prevention of infection |
| 01/25/2011 | US7875438 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 01/25/2011 | US7875437 Expression vector comprising nucleotide sequences coding streptococcal surface protein for use in detection, prevention and treatment of microorganismal infection |
| 01/25/2011 | US7875423 hepatitis b virus (HBV) variants with reduced sensitivity to agents and/or reduced interactivity with immunological reagents; detecting adefovir dipivoxil resistance |
| 01/25/2011 | US7875422 Viral drug susceptibility testing |
| 01/25/2011 | US7875280 Methods and compositions involving LcrV proteins |
| 01/25/2011 | US7875279 intermediates of the mevalonate-independent pathway for isoprenoid biosynthesis are enriched by deleting or inactivating genes; asthma, morbus Crohn, colitis ulcerosa, multiple sclerosis and chronic bronchitis and immune and auto-immune diseases and allergies and bone diseases and osteoporosis |
| 01/25/2011 | US7875278 antibodies exhibit increased antibody-dependent cellular cytotoxicity activity; humanizing, chimera |
| 01/25/2011 | US7875277 Antibodies target laminin 5 alpha 3 G4-G5 domain |
| 01/25/2011 | US7875259 Generating prion specific immunoglobulin for use in diagnosis, prevention and treatment of neurodegenerative disorders |
| 01/25/2011 | CA2635963C Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
| 01/25/2011 | CA2529965C Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases |
| 01/25/2011 | CA2525499C Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
| 01/25/2011 | CA2430182C Prokaryotically produced antibodies and uses thereof |
| 01/25/2011 | CA2405030C Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| 01/25/2011 | CA2340786C Vaccine comprising cytokine-induced heat shock proteins (hsp) |
| 01/25/2011 | CA2338186C Tumor necrosis factor-gamma |
| 01/25/2011 | CA2333833C Specific binding molecules for scintigraphy,conjugates containing them and therapeutic method for treatment of angiogenesis |
| 01/25/2011 | CA2295540C Improved anti-ige antibodies and method of improving polypeptides |
| 01/25/2011 | CA2224309C Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection |
| 01/20/2011 | WO2011009119A2 Compositions and methods for diagnosing and treating fibrotic disorders |
| 01/20/2011 | WO2011009090A1 Antibodies to high molecular weight melanoma associated antigen |
| 01/20/2011 | WO2011009042A2 Antigen compositions and methods of inhibiting campylobacter jejuni bacterial infection and uses of the antigen compositions |
| 01/20/2011 | WO2011008974A2 Rsv f protein compositions and methods for making same |
| 01/20/2011 | WO2011008958A1 Supralingual vaccines and applicators |
| 01/20/2011 | WO2011008956A2 Mammalian genes involved in infection |
| 01/20/2011 | WO2011008863A2 Stereoisomer peptides and their polymer conjugates for hiv disease |
| 01/20/2011 | WO2011008773A2 Mesenchymal stem cell differentiation |
| 01/20/2011 | WO2011008548A1 Vaccines and compositions against streptococcus pneumoniae |
| 01/20/2011 | WO2011008086A1 Mixture of non-digestible oligosaccharides for stimulating the immune system |
| 01/20/2011 | WO2011007853A1 Monoclonal antibody for cancer-specific isoform |
| 01/20/2011 | WO2011007787A1 Cancer therapeutic agent comprising antibody against cancer-specific membrane antigen |
| 01/20/2011 | WO2011007363A1 A composition useful as rotavirus vaccine and a method therefor. |
| 01/20/2011 | WO2011007359A2 Antigen specific multi epitope -based anti-infective vaccines |
| 01/20/2011 | WO2011007257A1 Detoxified escherichia coli immunogens |
| 01/20/2011 | WO2011007007A1 Orally administered bacteria as vehicles for systemic delivery of agents |
| 01/20/2011 | WO2011007004A1 Treatment of infections |
| 01/20/2011 | WO2011006914A2 Antagonists, uses & methods for partially inhibiting tnfr1 |
| 01/20/2011 | WO2011006823A1 Production of polio virus at high titers for vaccine production |
| 01/20/2011 | WO2011006219A1 Process and composition for treatment of canine and human leishmaniasis |
| 01/20/2011 | WO2010127294A3 Dual variable domain immunoglobulins and uses thereof |
| 01/20/2011 | WO2010118243A3 Use of il-27 antagonists to treat lupus |
| 01/20/2011 | WO2010109325A3 Combinations including pneumococcal serotype 14 saccharide |
| 01/20/2011 | WO2010107658A3 Methods and compositions for bi-specific targeting of cd19/cd22 |
| 01/20/2011 | WO2010100632A3 Chlamydia antigens |
| 01/20/2011 | WO2010092185A3 Scramblase/cd4 interaction inhibitors for the treatment of lentivirus infections |
| 01/20/2011 | WO2009155180A8 Antibodies to il-6 and their uses |
| 01/20/2011 | WO2003034984A9 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 01/20/2011 | US20110016544 Methods and compositions for detecting and treating retinal diseases based on metargidin (ADAM-15) |
| 01/20/2011 | US20110016537 Cellular model of tauopathies for lead identification and drug discovery |
| 01/20/2011 | US20110015376 Papilloma Virus-Like Particles, Fusion Proteins as Well as Processes for Their Production |
| 01/20/2011 | US20110015370 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/20/2011 | US20110014628 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy |
| 01/20/2011 | US20110014274 Vaccine composition containing synthetic adjuvant |
| 01/20/2011 | US20110014272 Method for adjuvanting lipopolysaccharide (LPS) of Gram-negative bacteria |
| 01/20/2011 | US20110014270 Prevention and treatment of ischemia-reperfusion injury and related conditions |
| 01/20/2011 | US20110014242 Promoters for expression in modified vaccinia virus ankara |
| 01/20/2011 | US20110014241 Therapeutic Cancer Antigens |
| 01/20/2011 | US20110014240 Single cycle replicating adenovirus vectors |
| 01/20/2011 | US20110014239 Preparation of Vaccines Using Photosensitizer and Light |
| 01/20/2011 | US20110014238 Immunogenic protein pas n 1 from bahia grass pollen |
| 01/20/2011 | US20110014237 Vaccine for Protection Against Haemophilus Parasuis Serotype 4 in Piglets |
| 01/20/2011 | US20110014236 Novel protein capable of inhibiting anthrax toxin activity |
| 01/20/2011 | US20110014235 Therapeutic and vaccine polyelectrolyte nanoparticle compositions |
| 01/20/2011 | US20110014234 Monoparamunity inducers based on attenuated rabbit myxoma viruses |
| 01/20/2011 | US20110014233 Psoralen-inactivated viral vaccine and method of preparation |
| 01/20/2011 | US20110014232 Chimeric foot and mouth disease viruses |
| 01/20/2011 | US20110014231 Anti-measles cancer immunotherapy |
| 01/20/2011 | US20110014230 preparation of influenza virus vaccine antigens |
| 01/20/2011 | US20110014229 Chimeric flavivirus vectors |
| 01/20/2011 | US20110014228 Il23 modified viral vector for recombinant vaccines and tumor treatment |
| 01/20/2011 | US20110014227 Pre-or post-exposure treatment for filovirus or arenavirus infection |
| 01/20/2011 | US20110014226 high throughput protein interaction assay |
| 01/20/2011 | US20110014225 Cross-reactive determinants and methods for their identification |
| 01/20/2011 | US20110014224 Methods for producing an immune response to tuberculosis |
| 01/20/2011 | US20110014223 Multimeric proteins able to induce an antibody response against the beta-amyloid and use thereof |
| 01/20/2011 | US20110014222 Stereoisomer Peptides and Their Polymer Conjugates for HIV Disease |
| 01/20/2011 | US20110014221 Hiv combination vaccine and prime boost |
| 01/20/2011 | US20110014220 Human respiratory syncytial virus (rsv) vaccine |
| 01/20/2011 | US20110014219 Norovirus and Sapovirus antigens |
| 01/20/2011 | US20110014218 Ixodes scapularis salivary proteins and methods of use for modulation of the alternative complement pathway |
| 01/20/2011 | US20110014217 Carbon nanotube compositions and methods of use thereof |